Citations

Clear

3942 citation(s) found for "To, Van".

Phenotyping of subjects for large scale studies on patients with IBS
Dumitraşcu, Dan L. , Farmer, A D, Hammer, Johann , Hausken, Trygve , Niesler, Beate , Pohl, Daniel , Pojskić, Lejla , Polster, Annikka , Goebel‐Stengel, Miriam , Oudenhove, Lukas Van , Vassallo, Mario, Wensaas, Knut‐Arne , Aziz, Qasim , Houghton, Lesley A. , members, COST Action BM1106 GENIEUR, Boeckxstaens, Guy E. , Drug, Vasile Liviu , Simrén, Magnus , members, COST Action BM1106 GENIEUR, Houghton, L A , Kapur-Pojskič, Lejla , Farmer, Adam D

Mayo Clinic

Neurogastroenterology & Motility | June 20, 2016 | Volume: 28 | Issue: 8 | Pages: 1134-1147

10.1111/nmo.12886 | PMID 27319981 Get It

Abstract Background Irritable bowel syndrome (IBS) is a complex condition with multiple factors contributing to its aetiology and pathophysiology. Aetiologically these include genetics, life‐time events and environment, and physiologically, changes in motility, central processing, visceral sensitivity, immunity, epithelial permeability and gastrointestinal microflora. Such complexity means there is currently no specific reliable biomarker for IBS, and thus IBS continues to be diagnosed and classified according to symptom based criteria, the Rome Criteria. Carefully phenotyping and characterisation of a ‘large’ pool of IBS patients across Europe and even the world however, might help identify sub‐populations with accuracy and consistency. This will not only aid future research but improve tailoring of treatment and health care of IBS patients. Purpose The aim of this position paper is to discuss the requirements necessary to standardize the process of selecting and phenotyping IBS patients and how to organise the collection and storage of patient information/samples in such a large multi‐centre pan European/global study. We include information on general demographics, gastrointestinal symptom assessment, psychological factors, quality of life, physiological evaluation, genetic/epigenetic and microbiota analysis, biopsy/blood sampling, together with discussion on the organisational, ethical and language issues associated with implementing such a study. The proposed approach and documents selected to be used in such a study was the result of a thoughtful and thorough four‐year dialogue amongst experts associated with the European COST action BM1106 GENIEUR ( www.GENIEUR.eu ).
External validation of a prognostic model of preoperative risk factors for failure of restorative proctocolectomy
Sahami, Saloomeh , Bartels, S. A. L., D’Hoore, A., Fadok, Tonia Young, Tanis, Pieter J. , Overstraeten, A. de Buck van, Bemelman, Willem A. , Overstraeten, Anthony de Buck van , Wolthuis, Albert M. , Buskens, Christianne Johanna

Mayo Clinic

Colorectal Disease | June 18, 2016 | Volume: 19 | Issue: 2 | Pages: 181-187

10.1111/codi.13414 | PMID 27315787 Get It

AbstractAimThe Cleveland Clinic has proposed a prognostic model of preoperative risk factors for failure of restorative proctocolectomy (RPC) with ileal pouch–anal anastomosis. The model incorporates four predictive variables: completion proctectomy, handsewn anastomosis, diabetes mellitus and Crohn's disease. The aim of the present study was to perform an external validation of this model in a new cohort of patients who had RPC.MethodValidation was performed in a multicentre cohort of 747 consecutive patients who had an RPC between 1990 and 2015 in three tertiary‐care facilities, using a Kaplan–Meier survival analysis and Cox regression analysis. The performance of the model was expressed using the Harrell concordance error rate. The primary outcome measure was pouch survival with maintenance of anal function.ResultsDuring the study period, 45 (6.0%) patients experienced failure at a median interval of 31 months (interquartile range 9–82 months) from the original RPC. Multivariable analysis showed handsewn anastomosis to be the only significant independent predictor. The Harrell concordance error rate was 0.42, indicating poor performance. Anastomotic leakage and Crohn's disease of the pouch were strong postoperative predictors for pouch failure and showed a significant difference in pouch survival after 10 years (P < 0.001).ConclusionThe poor performance of the Cleveland Clinic prognostic model makes it unsuitable for daily clinical practice. Handsewn anastomosis was associated with pouch failure in our cohort with relatively few events. A prediction model for anastomotic leakage or Crohn's disease of the pouch may be a better solution since these variables are strongly associated with pouch failure.
Teaching Video Neuro Images : Palatal tremor in adult-onset Alexander disease
Sebesto, Jason R., Gerpen, Jay A. van, Van Gerpen, Jay A

Mayo Clinic

Neurology | June 13, 2016 | Volume: 86 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000002763 | PMID 27298457 Get It

Affinity Selection of FGF2-Binding Heparan Sulfates for Ex Vivo Expansion of Human Mesenchymal Stem Cells
Wijesinghe, Sampath Jeewantha , Murali, Sadasivam, Qing, Yeong Hui, Hinkley, Simon F.R. , Carnachan, Susan , Bell, Tracey , Swaminathan, Kunchithapadam , Hui, James Hoi Po , Wijnen, André J. van , Nurcombe, Victor , Cool, Simon M. , van Wijnen, Andre J, Ling, Ling , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | June 13, 2016 | Volume: 232 | Issue: 3 | Pages: 566-575

10.1002/jcp.25454 | PMID 27291835 Get It

Proteasome inhibitor associated thrombotic microangiopathy
Yui, Jennifer , Keer, Jan Van , Weiss, Brendan M. , Waxman, Adam , Palmer, Matthew B. , D’Agati, Vivette D. , Kastritis, Efstathios , Dimopoulos, Meletios Α. , Vij, Ravi , Dingli, David , Nasr, Samih H. , Yui, Jennifer C, Bansal, Dhruv , Leung, Nelson , Dimopoulos, Meletios A , Dingli, David , Kastritis, Efstathios

Mayo Clinic

American Journal of Hematology | June 11, 2016 | Volume: 91 | Issue: 9 | Pages: No page available

10.1002/ajh.24447 | PMID 27286661 Get It

A variety of medications have been implicated in the causation of thrombotic microangiopathy (TMA). Recently, a few case reports have emerged of TMA attributed to the proteasome inhibitors (PI) bortezomib and carfilzomib in patients with multiple myeloma. The aim of this case series was to better characterize the role of PI in the etiology of drug‐induced TMA. We describe eleven patients from six medical centers from around the world who developed TMA while being treated with PI. The median time between medication initiation and diagnosis of TMA was 21 days (range 5 days to 17 months). Median laboratory values at diagnosis included hemoglobin—7.5 g dL−1, platelet count—20 × 109/L, LDH—698 U L−1, creatinine—3.12 mg dL−1. No patient had any other cause of TMA, including ADAMTS13 inhibition, other malignancy or use of any other medication previously associated with TMA. Nine patients had resolution of TMA without evidence of hemolysis after withdrawal of PI. Two patients had stabilization of laboratory values but persistent evidence of hemolysis despite medication withdrawal. One patient had recurrence of TMA with rechallenge of PI. There is a strong level of evidence that PI can cause DITMA. In evaluating patients with suspected TMA, PI use should be recognized as a potential etiology, and these medications should be discontinued promptly if thought to be the cause of TMA. Am. J. Hematol. 91:E348–E352, 2016. © 2016 Wiley Periodicals, Inc.
Brain Herniation into Arachnoid Granulations: Clinical and Neuroimaging Features
Lane, John I. , Eckel, Laurence J. , Schwartz, Kara M., Liebo, Greta B. , Lane, John Jack I, Van Gompel, Jamie J, Lehman, Vance T. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neuroimaging | June 8, 2016 | Volume: 26 | Issue: 6 | Pages: 592-598

10.1111/jon.12366 | PMID 27273503 Get It

ABSTRACTBACKGROUND/PURPOSEBrain herniation into presumed arachnoid granulations (BHAG) is an increasingly recognized entity. Though it has previously been described as isointense to brain matter on magnetic resonance imaging (MRI), we have encountered 21 cases in our clinical practice, many of which have signal abnormality in the herniated or adjacent parenchyma. We performed a systematic analysis on these cases to further understand the clinical significance.METHODSThis is a retrospective analysis of cases collected from our clinical MRI practice. Each case was evaluated for location, size, lobe of origin, associated signal abnormality, symptoms, and the presence or absence of intracranial hypertension.RESULTSTwenty‐one cases of BHAG identified in 16 patients. Seven cases (7/21, 33%) demonstrated signal abnormality in the herniated or underlying parenchyma. On serial imaging, the size of herniation either fluctuated (2/10, 20%) or stayed the same (8/10, 80%). The associated signal abnormalities increased (1/5, 20%), decreased (1/5, 20%), or remained stable (3/5, 60%). Four patients (4/16, 25%) had signs/symptoms that could be associated with the BHAG. Ten patients (10/16, 63%) had either imaging findings or clinical signs that could be associated with intracranial hypertension.CONCLUSIONIn contrast to previously reported cases, our study demonstrates that BHAG can be associated with MRI signal abnormalities of the herniated and adjacent brain. Symptoms are typically absent, though may be present in a small subset of patients, regardless of the presence of signal change or encephalomalacia of the involved brain. Indirect evidence of intracranial hypertension is present in a majority of patients but completely lacking in others.
Ethanol Extract of Cissus quadrangularis Enhances Osteoblast Differentiation and Mineralization of Murine Pre-Osteoblastic MC3T3-E1 Cells
Tasadduq, Raazia , Gordon, Jonathan , Lian, Jane B. , Wijnen, André J. van , Stein, Janet L. , Shakoori, Abdul Rauf , van Wijnen, Andre J, Gordon, Jonathan , Al‐Ghanim, Khalid A. , Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | June 6, 2016 | Volume: 232 | Issue: 3 | Pages: 540-547

10.1002/jcp.25449 | PMID 27264191 Get It

Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms
Mughal, Tariq I. , Rampal, Raajit K. , Koschmieder, Steffen , Levine, Ross L. , Hehlmann, Rüdiger , Saglio, Giuseppe , Barbui, Tiziano , Etten, Richard A. Van , Mesa, Ruben, Abdel‐Wahab, Omar , Mesa, Ruben A. , Koschmieder, Steffen

Mayo Clinic

Leukemia & Lymphoma | May 31, 2016 | Volume: 57 | Issue: 7 | Pages: 1517-1526

10.1080/10428194.2016.1185783 | PMID 27240645 Get It

The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas
Fang, Dong, Gan, Haiyun , Lee, Jeong‐Heon , Han, Jing, Wang, Zhiquan , Riester, Scott M. , Jin, Long , Chen, Jianji , Zhou, Hui , Wang, Jinglong , Zhang, Honglian , Bradley, Elizabeth W. , Ho, Thai H. , Bridge, Julia A. , Thibodeau, Stephen N. , Ördög, Tamás , Chen, Yue , Wijnen, André J. van , Oliveira, André M. , Xu, Rui-Ming , Zhang, Zhiguo , van Wijnen, Andre J, Fang, Dong, Yang, Na , Rubin, Brian P. , Westendorf, Jennifer J. , van Wijnen, Andre J , Ho, Thai , Bradley, Elizabeth W , Zhang, Zhiguo , Lee, Jeong-Heon , Wang, Zhiquan

Mayo Clinic

Science | May 27, 2016 | Volume: 352 | Issue: 6291 | Pages: 1344-1348

10.1126/science.aae0065 | PMID 27229140 Get It

A cancer-promoting histone protein Mutations in the chromatin protein histone H3 are found in a number of pediatric cancers. The lysine-36–to–methionine (K36M) “oncohistone” mutation is seen in almost all chondroblastomas. Fang et al. show that the K36M mutant histones inhibit the normal methylation of this same residue in wild-type H3 histones. They do so by interfering with the enzymes that normally methylate this residue. The altered chromatin methylation patterns alter the expression of known cancer-related genes and impart cancer-related characteristics to the chondrocyte cells. Science , this issue p. 1344